Xbiotech Stock Technical Analysis
| XBIT Stock | USD 2.51 0.03 1.18% |
As of the 31st of January, XBiotech maintains the Downside Deviation of 3.51, market risk adjusted performance of 0.052, and Mean Deviation of 3.26. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of XBiotech, as well as the relationship between them.
XBiotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as XBiotech, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to XBiotechXBiotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.XBiotech Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 18.0 | Strong Sell | 0 | Odds |
Most XBiotech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand XBiotech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of XBiotech, talking to its executives and customers, or listening to XBiotech conference calls.
XBiotech Analyst Advice DetailsIs there potential for Biotechnology market expansion? Will XBiotech introduce new products? Factors like these will boost the valuation of XBiotech. Anticipated expansion of XBiotech directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about XBiotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share | Quarterly Revenue Growth (0.93) | Return On Assets | Return On Equity |
XBiotech's market price often diverges from its book value, the accounting figure shown on XBiotech's balance sheet. Smart investors calculate XBiotech's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since XBiotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between XBiotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if XBiotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XBiotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
XBiotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XBiotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XBiotech.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in XBiotech on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding XBiotech or generate 0.0% return on investment in XBiotech over 90 days. XBiotech is related to or competes with Nutriband, Adagene, Fortress Biotech, Tscan Therapeutics, CervoMed, Gain Therapeutics, and Lite Strategy. XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for... More
XBiotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XBiotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XBiotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.51 | |||
| Information Ratio | 0.0049 | |||
| Maximum Drawdown | 28.09 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 6.67 |
XBiotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XBiotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XBiotech's standard deviation. In reality, there are many statistical measures that can use XBiotech historical prices to predict the future XBiotech's volatility.| Risk Adjusted Performance | 0.0216 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0065 | |||
| Treynor Ratio | 0.042 |
XBiotech January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0216 | |||
| Market Risk Adjusted Performance | 0.052 | |||
| Mean Deviation | 3.26 | |||
| Semi Deviation | 3.36 | |||
| Downside Deviation | 3.51 | |||
| Coefficient Of Variation | 5524.41 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.64 | |||
| Information Ratio | 0.0049 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0065 | |||
| Treynor Ratio | 0.042 | |||
| Maximum Drawdown | 28.09 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 6.67 | |||
| Downside Variance | 12.32 | |||
| Semi Variance | 11.29 | |||
| Expected Short fall | (4.22) | |||
| Skewness | 1.61 | |||
| Kurtosis | 4.86 |
XBiotech Backtested Returns
XBiotech appears to be moderately volatile, given 3 months investment horizon. XBiotech shows Sharpe Ratio of 0.054, which attests that the company had a 0.054 % return per unit of risk over the last 3 months. We have found thirty technical indicators for XBiotech, which you can use to evaluate the volatility of the entity. Please utilize XBiotech's Mean Deviation of 3.26, market risk adjusted performance of 0.052, and Downside Deviation of 3.51 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, XBiotech holds a performance score of 4. The firm maintains a market beta of 1.77, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, XBiotech will likely underperform. Please check XBiotech's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether XBiotech's historical returns will revert.
Auto-correlation | -0.21 |
Weak reverse predictability
XBiotech has weak reverse predictability. Overlapping area represents the amount of predictability between XBiotech time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XBiotech price movement. The serial correlation of -0.21 indicates that over 21.0% of current XBiotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
XBiotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
XBiotech Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of XBiotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About XBiotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of XBiotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of XBiotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on XBiotech price pattern first instead of the macroeconomic environment surrounding XBiotech. By analyzing XBiotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of XBiotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to XBiotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.2 | 0.18 | Price To Sales Ratio | 23.98 | 14.88 |
XBiotech January 31, 2026 Technical Indicators
Most technical analysis of XBiotech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for XBiotech from various momentum indicators to cycle indicators. When you analyze XBiotech charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0216 | |||
| Market Risk Adjusted Performance | 0.052 | |||
| Mean Deviation | 3.26 | |||
| Semi Deviation | 3.36 | |||
| Downside Deviation | 3.51 | |||
| Coefficient Of Variation | 5524.41 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.64 | |||
| Information Ratio | 0.0049 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0065 | |||
| Treynor Ratio | 0.042 | |||
| Maximum Drawdown | 28.09 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 6.67 | |||
| Downside Variance | 12.32 | |||
| Semi Variance | 11.29 | |||
| Expected Short fall | (4.22) | |||
| Skewness | 1.61 | |||
| Kurtosis | 4.86 |
XBiotech January 31, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as XBiotech stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | (0.19) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 2.59 | ||
| Day Typical Price | 2.56 | ||
| Price Action Indicator | (0.10) | ||
| Market Facilitation Index | 0.16 |
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.